Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4+ and CD8+ T cell responses in humansIan D. Davis, Jonathan Cebon, Tsin Yee Tai et al.|Proceedings of the National Academy of Sciences|2004Cited by 440
Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancersElke Jäger, Alexander Knuth, Eric W. Hoffman et al.|Proceedings of the National Academy of Sciences|2000Cited by 426